Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Assessing the hazard of death, cardiac tamponade, and pericardial constriction among HIV and tuberculosis pericarditis patients using the extended Cox-hazard model: Intervention study.Health science reports · 2024
   Article
2. Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome.Frontiers in neurology · 2022
   Article
3. Six months therapy for tuberculous meningitis.The Cochrane database of systematic reviews · 2016
   Review
4. Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia.Journal of neuroinflammation · 2007
   Article
5. Dexamethasone for adult bacterial meningitis.Current neurology and neuroscience reports · 2007
   Article

Corrections and comments

• Comment on
  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.2004

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as